Komori
TSUDAKOMA Corp. (6217) · PolicyRestated

Continuation of Research and Development Activities

First written in FY2016-Q2. 25 of 26 entries say "Restated". Latest entry: FY2024-Q1.

26entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016-Q2 – FY2024-Q12016: 220162017: 420172018: 420182019: 420192020: 420202021: 320212022: 220222023: 120232024: 2
Same theme, other companies
Continuation of R&D activities with no change in statusA theme 192 companies write about · 0 as a headwind · 181 as a tailwind

96 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 192 companies compared. The sentences above are computed from all 192.
Full recordFilings, disclosures and news, newest first
  1. FY2024-Q1RestatedAnnual report

    「The amount of the Group’s main research and development activities during the three-month period of the current fiscal year was ¥306 million. There were no material changes in the Group’s research and development activities during the three-month period of the current fiscal year.」

    The Company is continuing its activities, recognizing no material changes in research and development activities, and recorded ¥306 million in research and development expenses.
  2. FY2023RestatedAnnual report

    「In research and development, the Company continues to develop strategic products in response to increasingly diverse and sophisticated market needs in order to secure a competitive advantage in global markets. Total research and development expenses for the current fiscal year were ¥1,292 million.」

    The Company continued research and development of strategic products, and research and development expenses for the year were ¥1,292 million.
  3. FY2023-Q2RestatedAnnual report

    「The amount of the Group’s main research and development activities during the six-month period of the current fiscal year was ¥627 million. There were no material changes in the Group’s research and development activities during the six-month period of the current fiscal year.」

    The Company is continuing its activities, recognizing no material changes in research and development activities, and recorded ¥627 million in research and development expenses.
  4. FY2022-Q3RestatedAnnual report

    「The amount of the Group’s main research and development activities during the nine-month period of the current fiscal year was ¥1,076 million. There were no material changes in the Group’s research and development activities during the nine-month period of the current fiscal year.」

    The Company is continuing its activities, recognizing no material changes in research and development activities, and recorded ¥1,076 million in research and development expenses.
  5. FY2022-Q2RestatedAnnual report

    「The amount of the Group’s main research and development activities during the six-month period of the current fiscal year was ¥729 million. There were no material changes in the Group’s research and development activities during the six-month period of the current fiscal year.」

    The Company is continuing its activities, recognizing no material changes in research and development activities, and recorded ¥729 million in research and development expenses.
  6. FY2021-Q3RestatedAnnual report

    「The amount of the Group’s main research and development activities during the nine-month period of the current fiscal year was ¥1,243 million. There were no material changes in the Group’s research and development activities during the nine-month period of the current fiscal year.」

    The Company is continuing its activities, recognizing no material changes in research and development activities, and recorded ¥1,243 million in research and development expenses.
  7. FY2021-Q2RestatedAnnual report

    「The amount of the Group’s main research and development activities during the six-month period of the current fiscal year was ¥811 million. There were no material changes in the Group’s research and development activities during the six-month period of the current fiscal year.」

    The Company is continuing its activities, recognizing no material changes in research and development activities, and recorded ¥811 million in research and development expenses.
  8. FY2021-Q1RestatedAnnual report

    「The amount of the Group’s main research and development activities during the three-month period of the current fiscal year was ¥393 million. There were no material changes in the Group’s research and development activities during the three-month period of the current fiscal year.」

    The Company is continuing its existing research and development policy, as there have been no material changes in its research and development activities.
  9. FY2020-Q3RestatedAnnual report

    「The amount of the Group’s main research and development activities during the nine-month period of the current fiscal year was ¥1,285 million. There were no material changes in the Group’s research and development activities during the nine-month period of the current fiscal year.」

    The company reported no significant changes in its research and development activities and continued its R&D efforts.
  10. FY2020-Q2RestatedAnnual report

    「The amount of the Group's principal research and development activities during the six months ended the second quarter was ¥871 million. There were no material changes in the Group's research and development activities during the six months ended the second quarter.」

    The company reported no significant changes in its research and development activities and continued its R&D efforts.
  11. FY2020-Q1RestatedAnnual report

    「The amount of the Group's principal research and development activities during the three months ended the first quarter was ¥438 million. There were no material changes in the Group's research and development activities during the three months ended the first quarter.」

    The Group confirmed its policy of continuing its research and development activities, stating that there were no material changes.
  12. FY2019RestatedAnnual report

    「In research and development, the Group continues to develop strategic products in response to increasingly diverse and sophisticated market needs in order to secure a competitive advantage in global markets. Total research and development expenses for the current fiscal year were ¥1,814 million.」

    The Group continued research and development of strategic products and recorded ¥1,814 million in research and development expenses.
  13. FY2019-Q3RestatedAnnual report

    「The amount of the Group's principal research and development activities during the nine months ended the third quarter was ¥1,370 million. There were no material changes in the Group's research and development activities during the nine months ended the third quarter.」

    The Group continued research and development of strategic products and other products, stating that there were no material changes in its research and development activities.
  14. FY2019-Q2RestatedAnnual report

    「The amount of the Group's principal research and development activities during the six months ended the second quarter was ¥908 million. There were no material changes in the Group's research and development activities during the six months ended the second quarter.」

    The Group confirmed its policy of continuing its research and development activities, stating that there were no material changes.
  15. FY2019-Q1RestatedAnnual report

    「The amount of the Group's principal research and development activities during the three months ended the first quarter was ¥456 million. There were no material changes in the Group's research and development activities during the three months ended the first quarter.」

    The Group confirmed its policy of continuing its research and development activities, stating that there were no material changes.
  16. FY2018RestatedAnnual report

    「In research and development, the Group continues to develop strategic products in response to increasingly diverse and sophisticated market needs in order to secure a competitive advantage in global markets. Total research and development expenses for the current fiscal year were ¥1,825 million.」

    The Group continued research and development of strategic products and recorded ¥1,825 million in research and development expenses.
  17. FY2018-Q3RestatedAnnual report

    「The amount of the Group's principal research and development activities during the nine months ended the third quarter was ¥1,343 million. There were no material changes in the Group's research and development activities during the nine months ended the third quarter.」

    The Group confirmed its policy of continuing its research and development activities, stating that there were no material changes.
  18. FY2018-Q2RestatedAnnual report

    「The amount of the Group's principal research and development activities during the six months ended the second quarter was ¥856 million. There were no material changes in the Group's research and development activities during the six months ended the second quarter.」

    The Group confirmed its policy of continuing its research and development activities, stating that there were no material changes.
  19. FY2018-Q1RestatedAnnual report

    「The amount of the Group's principal research and development activities during the three months ended the first quarter was ¥399 million. There were no material changes in the Group's research and development activities during the three months ended the first quarter.」

    The Group confirmed its policy of continuing its research and development activities, stating that there were no material changes.
  20. FY2017RestatedAnnual report

    「In research and development, the Group continues to develop strategic products in response to increasingly diverse and sophisticated market needs in order to secure a competitive advantage in global markets. Total research and development expenses for the current fiscal year were ¥1,615 million.」

    The Group continued research and development of strategic products and recorded ¥1,615 million in research and development expenses.
  21. FY2017-Q3RestatedAnnual report

    「The amount of the Group's principal research and development activities during the nine months ended the third quarter was ¥1,114 million. There were no material changes in the Group's research and development activities during the nine months ended the third quarter.」

    The Group stated that there were no material changes in its research and development activities and confirmed its policy of continuing them.
  22. FY2017-Q2RestatedAnnual report

    「The amount of the Group's principal research and development activities during the six months ended the second quarter was ¥716 million. There were no material changes in the Group's research and development activities during the six months ended the second quarter.」

    The Group stated that there were no material changes in its research and development activities and confirmed its policy of continuing them.
  23. FY2017-Q1RestatedAnnual report

    「The amount of the Group's principal research and development activities during the three months ended the first quarter was ¥361 million. There were no material changes in the Group's research and development activities during the three months ended the first quarter.」

    The Group stated that there were no material changes in its research and development activities and confirmed its policy of continuing them.
  24. FY2016RestatedAnnual report

    「In research and development, the Group continues to develop strategic products in response to increasingly diverse and sophisticated market needs in order to secure a competitive advantage in global markets. Total research and development expenses for the current fiscal year were ¥1,520 million.」

    The Group continued research and development of strategic products and recorded ¥1,520 million in research and development expenses.
  25. FY2016-Q3RestatedAnnual report

    「The amount of the Group's principal research and development activities during the nine months ended the third quarter was ¥1,117 million. There were no material changes in the Group's research and development activities during the nine months ended the third quarter.」

    The Group stated that there were no material changes in its research and development activities and indicated that it would continue them.
  26. FY2016-Q2First statedAnnual report

    「The amount of the Group's principal research and development activities during the six months ended the second quarter was ¥728 million. There were no material changes in the Group's research and development activities during the six months ended the second quarter.」

    The Group continued its research and development activities, with no material changes during the quarter.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
TSUDAKOMA Corp.'s next results are scheduled for 2026-10-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.